Cadrenal Therapeutics, Inc. Deferred Costs, Current
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredCostsCurrent · last filed 2026-08-13
- 2026-06-30: Deferred Costs, Current $95.67K.
- 2026-03-31: Deferred Costs, Current $113.61K.
- 2025-12-31: Deferred Costs, Current $106.34K.
- 2025-09-30: Deferred Costs, Current $90.84K.
| Period end | Deferred Costs, Current |
|---|---|
| 2026-06-30 | $95.67K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $113.61K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $106.34K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $90.84K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $23.86K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $8.45K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $14.45K 10-K · filed 2026-03-31 |
| 2024-09-30 | $116.88K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $171.38K 10-Q · filed 2024-08-07 |
| 2022-12-31 | $672.29K 10-Q · filed 2023-08-10 |